Recombinant tissue plasminogen activator (rt‐PA) utilisation by rural clinicians in acute ischaemic stroke: An audit of current practice and clinical outcomes

ConclusionRecombinant tissue plasminogen activator can be delivered in rural Australian hospitals in a timely manner within recommended implementation guidelines. Acute stroke thrombolytic services in rural Australian facilities had comparable outcomes to metropolitan facilities. Small numbers of thrombolysed patients prevented a validation study of the well‐defined outcome benefits from rt‐PA. The need for ongoing data collection in regional settings is supported.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fajr.12038

Source: Australian Journal of Rural Health - August 16, 2013 Category: Rural Health Authors: Jocelyn M. Williams, Tina J. Navin, Martin R. Jude, Christopher R. Levi Tags: Original Research Source Type: research